Release Date: 08/06/17 10:00 Summary: Suspension from Official Quotation - HMLOA Price Sensitive: Yes Download Document 241.8KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%